XML 127 R37.htm IDEA: XBRL DOCUMENT
v3.24.0.1

Investments in Other Entities (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2023
Equity Method Investments and Joint Ventures [Abstract] |
Schedule of Equity Method Investments, Financial Statement Information | For the twelve months ended December 31, 2023 and 2022, the Company’s equity method investment balance consisted of the following (in thousands):
| % of Ownership |  | December 31, 2022 |  |  |  | Initial Investment |  | Allocation of Net Income (Loss) |  |  | Funding |  | Adjustment of Fair Value* |  | Distribution |  | December 31, 2023
LaSalle Medical Associates – IPA Line of Business | 25% |  | $ | 5,684 |  |  |  |  | $ | — |  |  | $ | 4,182 |  |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 9,866 |
Pacific Medical Imaging & Oncology Center, Inc. | 40% |  | 1,878 |  |  |  |  | — |  |  | (187) |  |  |  | — |  |  | — |  |  | — |  |  | 1,691 |
531 W. College, LLC * | 50% |  | 17,281 |  |  |  |  | — |  |  | (508) |  |  |  | 700 |  |  | 91 |  |  | (17,564) |  |  | — |
One MSO, LLC * | 50% |  | 2,718 |  |  |  |  | — |  |  | 938 |  |  |  | — |  |  | 3,260 |  |  | (6,916) |  |  | — |
CAIPA MSO, LLC | 30% |  | 12,738 |  |  |  |  | — |  |  | 922 |  |  |  | — |  |  | — |  |  | — |  |  | 13,660 |
Other ** | 25% |  | — |  |  |  |  | 325 |  |  | 232 |  |  |  | — |  |  | — |  |  | — |  |  | 557 |
|  |  | $ | 40,299 |  |  |  |  | $ | 325 |  |  | $ | 5,579 |  |  |  | $ | 700 |  |  | $ | 3,351 |  |  | $ | (24,480) |  |  | $ | 25,774 |
* Investments deemed Excluded Assets that are solely for the benefit of APC and its common shareholders. These Excluded Assets were spun-off on December 26, 2023 as part of the Spin-Off. On the date of distribution, the investments were recorded at fair value. The gain, representing the difference between the fair value and the carrying value of the investment, was $3.4 million and is presented within other income in the accompanying consolidated statement of net income. Refer to Note 1 — “Description of Business” to the consolidated financial statements for information on the Spin-Off. ** Other consists of smaller equity method investments.
| % of Ownership |  | December 31, 2021 |  |  |  | Allocation of Net Income (Loss) |  | Funding Reclassified to Loan Receivable |  |  | Funding |  | Entity Consolidated |  | Distribution |  | December 31, 2022
LaSalle Medical Associates – IPA Line of Business | 25% |  | $ | 3,034 |  |  |  |  | $ | 4,775 |  |  | $ | (2,125) |  |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 5,684 |
Pacific Medical Imaging & Oncology Center, Inc. | 40% |  | 1,719 |  |  |  |  | 159 |  |  | — |  |  |  | — |  |  | — |  |  | — |  |  | 1,878 |
531 W. College, LLC * | 50% |  | 17,230 |  |  |  |  | (619) |  |  | — |  |  |  | 670 |  |  | — |  |  | — |  |  | 17,281 |
One MSO, LLC * | 50% |  | 2,910 |  |  |  |  | 408 |  |  | — |  |  |  | — |  |  | — |  |  | (600) |  |  | 2,718 |
Tag-6 Medical Investment Group, LLC* | 100% |  | 4,830 |  |  |  |  | 153 |  |  | — |  |  |  | 1,435 |  |  | (6,418) |  |  | — |  |  | — |
CAIPA MSO, LLC | 30% |  | 11,992 |  |  |  |  | 746 |  |  | — |  |  |  | — |  |  | — |  |  | — |  |  | 12,738 |
|  |  | $ | 41,715 |  |  |  |  | $ | 5,622 |  |  | $ | (2,125) |  |  |  | $ | 2,105 |  |  | $ | (6,418) |  |  | $ | (600) |  |  | $ | 40,299 |
* Investments deemed Excluded Assets that are solely for the benefit of APC and its common shareholders. These Excluded Assets were spun-off on December 26, 2023 as part of the Spin-off. Refer to Note 1 — “Description of Business” to the consolidated financial statements for information on the Spin-Off.

X
- References No definition available. + Details
Name: | us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3 + Details
Name: | us-gaap_EquityMethodInvestmentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration